Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Dynamite News
Dynamite News
World
DN Bureau

Scientists reveal why one type of chemotherapy works best in bladder cancer

Representational Image

Washington DC: According to a study published in Cell Reports Medicine in January, researchers at Tisch Cancer Institute showed that a certain form of chemotherapy boosts the immune system's ability to fight bladder cancer, especially when paired with immunotherapy.

These findings may explain why the approach, cisplatin chemotherapy, can lead to cure in a small subset of patients with metastatic, or advanced, bladder cancer. 

Read This Also: Cold water swimming improves menopause symptoms

Researchers also believe that their findings could explain why clinical trials combining another type of chemotherapy, carboplatin-based chemo, with immunotherapy have not been successful but others that use cisplatin with immunotherapy are successful.

"We have known for decades that cisplatin works better than carboplatin in bladder cancer, however, the mechanisms underlying those clinical observations have remained elusive until now," said the study's lead author Matthew Galsky, M.D., Co-Director of the Center of Excellence for Bladder Cancer at The Tisch Cancer Institute at Mount Sinai.

Read This Also: Hypertension guidelines do not include potassium-enriched salt

"This study provides clues as to why cisplatin-based chemotherapy may achieve durable disease control in a subset of patients with metastatic bladder cancer, provides clues as to which patients may derive such benefit, and provides a foundation for building even better treatment regimens that exploit the immunomodulatory effects of cisplatin-based chemotherapy."

Bladder cancer affects about 83,000 people in the United States annually. Metastatic bladder cancer is particularly hard to cure with current treatments, so these findings are an important step to most effectively use the drugs available and determine effective combination therapies.

The study found that cisplatin chemotherapy may work better when the body has generated a pre-existing, but restrained, immune response against the tumor. The study further found that cisplatin damages DNA in cancer cells, which may lead to changes in expression of genes that might improve the ability of the body's immune system to detect cancer cells. (ANI)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.